YOLFTbeta
06

Curexo Inc

060280 · KQ · Consumer Non-Cyclicals / Food & Drug Retailing

6,720.00KRW+60.00 (+0.90%)

Price History

Full chart

Market Stats

Previous Close6,660.00
Open6,720.00
Day Range6,710.00 – 7,180.00
52-Week Range6,970.00 – 22,550.00
Volume225.77K
Market Cap361.02B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.02
50-Day Avg8,418.20
200-Day Avg12,608.90

About

Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company also imports, distributes, and sells food and food additives. Curexo Inc. was founded in 2006 and is headquartered in Seoul, South Korea.

Company Details

  • SectorConsumer Non-Cyclicals
  • IndustryFood & Drug Retailing
  • CEOKyung-Hoon Lee
  • Employees0
  • Headquarters577, Gangnam-daero, Seoul, South Korea, Korea
  • Websitehttps://www.curexo.com

Leadership

  • Kyung-Hoon LeeChief Exec. Officer · b. 1966
  • Sung-Kwon KangSr. Managing Director · b. 1958
  • Bong-Choo KimManaging Director · b. 1967
  • Hoo-Rak DoVP · b. 1966
  • Youn-Jung YookExec. Officer
  • Jung-Eun ParkExec. Officer
  • Seung-Hoon OhExec. Officer
  • Chang-Hoon SongExec. Officer
  • Yong-Chan JungSr. Managing Director

Financials

Income Statement

Currency: KRW2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue26.94B50.13B28.93B26.03B4.02B33.89B24.28B31.09B26.14B27.53B30.06B33.48B33.89B34.39B39.28B42.79B64.99B72.88B55.53B74.53B
Growth (%)-+86.06%-42.30%-10.02%-84.55%+742.81%-28.35%+28.05%-15.93%+5.33%+9.19%+11.39%+1.21%+1.47%+14.23%+8.94%+51.87%+12.14%-23.81%+34.22%
Cost of Revenue25.64B44.79B21.47B20.86B727.69M25.28B21.73B27.19B22.77B25.09B25.45B27.62B27.74B28.83B29.92B33.74B50.60B53.58B40.90B49.69B
Gross Profit------2.56B3.90B3.36B2.44B4.62B5.87B6.15B5.56B9.36B9.06B14.39B19.30B14.63B24.84B
Gross Margin------10.52%12.55%12.87%8.88%15.35%17.52%18.14%16.18%23.83%21.16%22.14%26.48%26.34%33.33%
Operating Expense------16.70B17.94B24.10B27.08B48.07B5.31B16.90B12.73B9.37B14.10B15.05B18.16B20.45B22.48B
Operating Income-------14.15B-14.04B-20.73B-24.63B-43.45B556.43M-10.75B-7.17B-14.22M-5.04B-658.07M1.14B-5.82B2.36B
Operating Margin-------58.26%-45.16%-79.32%-89.47%-144.55%1.66%-31.71%-20.85%-0.04%-11.78%-1.01%1.56%-10.48%3.17%
EBITDA-----------------236.42M-2.75B-6.41B5.70B
EBITDA Margin-----------------0.36%-3.78%-11.54%7.65%
Net Income-------13.05B-7.47B-10.86B-9.40B24.15B-16.88B-29.42B-25.92B416.63M-2.34B-3.04B-4.86B-8.76B2.77B
Net Income Margin-------53.75%-24.01%-41.55%-34.15%80.34%-50.43%-86.81%-75.37%1.06%-5.47%-4.68%-6.66%-15.77%3.72%
R&D-----2.81B4.39B7.86B11.93B7.56B---6.25B4.67B5.43B6.04B7.60B9.47B10.43B
R&D as % of Total Revenue-----8.28%18.09%25.28%45.64%27.46%---18.16%11.88%12.68%9.29%10.43%17.05%13.99%
Interest Expense000000000000011.47M26.42M770.12M1.45B414.23M96.17M87.42M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.03%0.07%1.80%2.23%0.57%0.17%0.12%

Balance Sheet

Currency: KRW2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.75B40.41B47.70B31.15B27.01B88.07B51.43B39.54B40.34B58.63B78.25B75.55B73.34B47.13B48.88B61.31B98.40B107.37B102.58B101.14B
Total Liabilities9.37B12.14B11.66B11.07B3.67B55.67B1.95B4.45B26.39B25.12B5.17B4.86B3.31B3.15B4.08B18.40B16.72B6.94B9.20B4.89B
Total Equity28.38B28.27B27.34B15.69B15.66B39.92B37.82B30.45B19.11B33.51B73.08B70.69B70.03B43.98B44.79B42.90B81.68B100.43B93.38B96.25B
Cash2.75B2.07B8.36B4.09B6.69B24.09B22.99B7.97B7.11B18.25B402.41K641.46K401.46K161.16K706.36K419.46K664.46K1.19M480.14K18.69B
Total Debt-------------58.74M152.67M-----
Net Debt---------------2.87B5.19B---

Cash Flow

Currency: KRW2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow------19.59B-14.58B-20.06B-19.79B-58.79B-1.52B-15.20B-5.08B-1.53B-8.74B-13.08B5.08B3.85B-11.26B
Investing Cash Flow937.53M3.17B6.52B--23.17B-2.44B-2.32B-9.55B-2.83B-4.42B-9.36B3.61B2.20B-5.93B-28.17B11.17B-7.91B-
Financing Cash Flow945.48M-481.89M15.73B64.81B-6.76B2.00B21.52B40.47B46.83B3.68B26.43B376.18M-131.81M14.73B40.23B-386.84M708.78M-
Capital Expenditure282.08M327.10M974.00M564.06M89.51M1.39B816.92M2.08B3.05B1.23B685.71M2.38B358.69M816.30M805.15M540.59M2.28B3.38B2.51B
Free Cash Flow--------------2.35B-9.55B-13.62B2.80B465.06M-13.77B
FCF to OCF-------------153.35%109.21%104.13%55.04%12.08%122.33%

Earnings

Report DateSep 30, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011May 14, 2012Aug 15, 2012Nov 15, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Nov 27, 2013Dec 31, 2013May 29, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Feb 15, 2019Apr 15, 2019Aug 15, 2019Nov 15, 2019Feb 15, 2020May 13, 2020Aug 15, 2020Nov 13, 2020Feb 8, 2021May 14, 2021Aug 13, 2021Nov 5, 2021Mar 16, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 15, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 22, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------18.39---------------------------------------------------------
EPS Actual-58.07-46.796.95-14.1146.03-49.00-54.66-35.51-170.24-42.50-85.79-69.17-69.72-77.44-72.23-96.22-142.76-81.46-87.35-19.08-148.62-137.85-145.47-145.971293.64-181.29-132.71-136.84-137.50-176.17-161.92-158.99-399.99-191.20-199.74-193.82-192.23-22.69-26.6418.7443.03-348.003.00-32.00-17.83-12.26-40.0821.24-55.0747.4536.8113.04-213.83-9.03-35.06-38.11-130.9526.59-21.6620.0142.4811.1360.22
Surprise------166.45%---------------------------------------------------------
Timing-----After-hoursPre-marketPre-market---After-hours-Pre-market------------------After-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market---Pre-market---Pre-market----------

Key Statistics & Ratios

Market Cap361.02B
Enterprise Value294.55B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.16
Price / Book3.17
Revenue (TTM)27.85B
Gross Profit (TTM)2.40B
EBITDA-39.24B
Profit Margin-57.98%
Operating Margin-152.90%
Return on Equity-743.85%
Return on Assets-44.52%
Shares Outstanding33.36M
Shares Float14.73M
Beta1.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jan 11, 20181654:1575
  • Apr 5, 20062:1